Rising Cost of Psoriasis

Affecting over 3% of the U.S. Population, Psoriasis is a chronic inflammatory skin condition that can result in significant financial and emotional costs. Researchers indicate that as Psoriasis is often indicative of additional underlying conditions, that overall medical costs tend to increase with frequency and severity of flare-ups. The annual healthcare cost for Psoriasis is estimated at nearly $135 billion.

The cost of psoriasis treatment is comprised by 3 major categories based on the information reviewed including direct costs, indirect costs, and related health problems. Though approximately half of overall healthcare cost is related to diagnosis and treatment of Psoriasis directly, the total cost doubles including associated physical and mental health effects.

According to researchers, though the costs of Psoriasis can be significant, there are a variety of treatments for treating flare-ups. New injectable, oral, and topical Psoriasis medications are being developed to prevent and treat the condition.